155 related articles for article (PubMed ID: 26867352)
1. Actively personalized cancer vaccines--the step into clinical application.
Kloke BP; Kreiter S; Vormehr M; Diken M; Kuhn AN; Sahin U
Pharmazie; 2016 Jan; 71(1):43-7. PubMed ID: 26867352
[TBL] [Abstract][Full Text] [Related]
2. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.
Grabbe S; Haas H; Diken M; Kranz LM; Langguth P; Sahin U
Nanomedicine (Lond); 2016 Oct; 11(20):2723-2734. PubMed ID: 27700619
[TBL] [Abstract][Full Text] [Related]
3. Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format.
Diken M; Kreiter S; Kloke B; Sahin U
Prog Tumor Res; 2015; 42():44-54. PubMed ID: 26383626
[TBL] [Abstract][Full Text] [Related]
4. Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination.
Vormehr M; Schrörs B; Boegel S; Löwer M; Türeci Ö; Sahin U
J Immunol Res; 2015; 2015():595363. PubMed ID: 26844233
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer vaccines - a one-hit wonder?
Liu JK
Yale J Biol Med; 2014 Dec; 87(4):481-9. PubMed ID: 25506282
[TBL] [Abstract][Full Text] [Related]
6. Cancer vaccines: preclinical studies and novel strategies.
Palena C; Abrams SI; Schlom J; Hodge JW
Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
[TBL] [Abstract][Full Text] [Related]
7. Could immunosignatures technology enable the development of a preventative cancer vaccine?
Shen L; Hansen DT; Johnston SA; Legutki JB
Expert Rev Vaccines; 2014 May; 13(5):577-9. PubMed ID: 24641768
[TBL] [Abstract][Full Text] [Related]
8. Overcoming technical challenges in the development of cancer vaccines.
Dalgleish A
IDrugs; 2007 Jul; 10(7):463-7. PubMed ID: 17642016
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
10. IL-13 receptor-directed cancer vaccines and immunotherapy.
Nakashima H; Husain SR; Puri RK
Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
[TBL] [Abstract][Full Text] [Related]
11. Tissue vaccines for cancer.
Suckow MA; Heinrich J; Rosen ED
Expert Rev Vaccines; 2007 Dec; 6(6):925-37. PubMed ID: 18377356
[TBL] [Abstract][Full Text] [Related]
12. Advances in prophylactic cancer vaccine research.
Le Poole IC; Bommiasamy H; Bocchetta M; Kast WM
Expert Rev Anticancer Ther; 2003 Aug; 3(4):537-45. PubMed ID: 12934665
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic cancer vaccines: using unique antigens.
Lewis JJ
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14653-6. PubMed ID: 15297620
[TBL] [Abstract][Full Text] [Related]
14. Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?
Quesnel B
Expert Rev Vaccines; 2006 Dec; 5(6):773-81. PubMed ID: 17184216
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.
Kusmartsev S; Vieweg J
Nat Rev Urol; 2009 Oct; 6(10):540-9. PubMed ID: 19736551
[TBL] [Abstract][Full Text] [Related]
16. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
17. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
Emens LA; Jaffee EM
Cancer Res; 2005 Sep; 65(18):8059-64. PubMed ID: 16166275
[TBL] [Abstract][Full Text] [Related]
18. Discovery and development of therapeutic cancer vaccines.
Acres B; Limacher JM; Bonnefoy J
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):185-92. PubMed ID: 17436554
[TBL] [Abstract][Full Text] [Related]
19. A novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma.
Figlin RA
Immunotherapy; 2014; 6(3):261-8. PubMed ID: 24354908
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
